CLINUVEL PHARMACEUTICALS LTD (ASX: CUV; NASDAQ INTERNATIONAL DESIGNATION ADR: CLVLY; XETRA-DAX: UR9) is a global and diversified biopharmaceutical company focused on developing and commercialising treatments for patients with genetic, metabolic, and life-threatening disorders, as well as healthcare solutions for the general population. As pioneers in photomedicine and understanding the interaction of light and human biology, CLINUVEL’s research and development has led to innovative treatments for patient populations with a clinical need for systemic photoprotection, DNA repair and acute or life threatening conditions. These patient groups range in size from 5,000 to 45 million worldwide. CLINUVEL’s lead compound, SCENESSE® (afamelanotide 16mg), was approved by the European Commission in 2014 and the US Food and Drug Administration in 2019 for the prevention of phototoxicity (anaphylactoid reactions and burns) in adult patients with erythropoietic protoporphyria (EPP). More information on EPP can be found at http://www.epp.care. Headquartered in Melbourne, Australia, CLINUVEL has operations in Europe, Singapore, and the USA. For more information please go to http://www.clinuvel.com.
SCENESSE® and PRÉNUMBRA® are registered trademarks of CLINUVEL PHARMACEUTICALS LTD
Company Details
- Employees
- 81
- Founded
- -
- Address
- Level 22, 535 Bourke Street, Melbourne,victoria 3000,australia
- Phone
- 61 3 9660 4900
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- clinuvel.com
- Keywords
- Drug development, Drug commercialisation, Photomedicine, Rare diseases, Pharmaceutical, Photoprotection, Erythropoietic protoporphyria, Photocare, Biotechnology.
- HQ
- Melbourne, Victoria
Clinuvel Pharmaceuticals Ltd Questions
Clinuvel Pharmaceuticals Ltd's helpline number is 61 3 9660 4900
Clinuvel Pharmaceuticals Ltd's website is clinuvel.com
Clinuvel Pharmaceuticals Ltd's LinkedIn profile is https://www.linkedin.com/company/clinuvel-pharmaceuticals-ltd
Clinuvel Pharmaceuticals Ltd has
81 employees.
View email and phone details for 81
employees at Clinuvel Pharmaceuticals Ltd.
Clinuvel Pharmaceuticals Ltd's industry is
Biotechnology Research
Clinuvel Pharmaceuticals Ltd's top competitors are
Medpace,
Neuren Pharmaceuticals Limited,
Mayne Pharma,
Amgen,
Mesenbio,
Recce Pharmaceuticals Ltd,
Mesoblast Limited,
Abbvie,
Soltégo,
Telix Pharmaceuticals Limited.
Clinuvel Pharmaceuticals Ltd's categories are Biotechnology Research
Clinuvel Pharmaceuticals Ltd's founding year is 2001
